# SLC30A8

## Overview
The SLC30A8 gene encodes the protein solute carrier family 30 member 8 (ZnT8), a zinc transporter predominantly expressed in pancreatic β-cells. ZnT8 is a member of the cation diffusion facilitator family and is characterized by its transmembrane structure, which facilitates the transport of zinc ions into insulin secretory granules. This process is essential for the crystallization and storage of insulin, thereby playing a critical role in insulin secretion and glucose homeostasis (Weijers2010Threedimensional; Davidson2014Zinc). Variants in the SLC30A8 gene have been associated with altered insulin secretion and an increased risk of type 2 diabetes mellitus, highlighting its clinical significance in metabolic disorders (BarragánÁlvarez2021Loss; Tamaki2013The). The protein's interactions with other molecules involved in insulin regulation further underscore its importance in maintaining glucose homeostasis and its potential impact on diabetes pathogenesis (Mitchell2016Molecular).

## Structure
The SLC30A8 gene encodes the ZnT-8 protein, a zinc transporter specifically expressed in pancreatic β-cells. The primary structure of ZnT-8 includes a sequence of amino acids that form the protein, which is part of the cation diffusion facilitator family. The secondary structure of ZnT-8 is characterized by six transmembrane α-helical segments, which are crucial for its zinc transporting function (Weijers2010Threedimensional; Kambe2012Molecular). The tertiary structure of ZnT-8 features a Y-shaped architecture with a C-terminal domain exhibiting an αββαβ fold, modeled based on the E. coli zinc transporter YiiP (Weijers2010Threedimensional; Lu2007Structure). This C-terminal domain includes three β-strands and two α-helices (Weijers2010Threedimensional).

The quaternary structure of ZnT-8 involves the formation of homodimers, which is essential for its zinc transport activity (Kambe2012Molecular). The protein's function is attributed to its hydrophobic N-terminal domain, while the C-terminal domain is hydrophilic and variable (Weijers2010Threedimensional). The ZnT-8 protein may undergo post-translational modifications, such as phosphorylation, which can affect its activity and stability. Splice variants of ZnT-8 may exist, potentially leading to different isoforms with distinct functions (Kambe2012Molecular).

## Function
The SLC30A8 gene encodes the zinc transporter protein ZnT8, which is primarily expressed in pancreatic beta cells. ZnT8 plays a crucial role in the transport of zinc ions into insulin secretory granules, where zinc is essential for the crystallization and storage of insulin. This process is vital for the proper secretion of insulin in response to glucose levels (Chimienti2006In; Davidson2014Zinc). ZnT8 is localized on the membrane of insulin-containing secretory vesicles and the Golgi compartment within beta cells, maintaining high zinc concentrations necessary for insulin processing and storage (Wong2017Exploring).

Zinc co-secreted with insulin also plays roles in auto- and paracrine signaling, such as inhibiting glucagon secretion from neighboring alpha cells (Flannick2016SLC30A8:). The transporter is involved in regulating hepatic insulin clearance, as zinc secreted with insulin suppresses hepatic insulin clearance by inhibiting clathrin-dependent insulin endocytosis (Tamaki2013The). Variants in SLC30A8, such as the R325W polymorphism, have been associated with altered insulin secretion and clearance, impacting glucose homeostasis and potentially influencing the risk of type 2 diabetes (Tamaki2013The; Davidson2014Zinc).

## Clinical Significance
Mutations in the SLC30A8 gene, which encodes the zinc transporter 8 (ZnT8), have significant clinical implications, particularly in relation to type 2 diabetes mellitus (T2DM). Variants such as the p.Arg138* and p.Lys34Serfs*50 are rare truncated mutations that have been associated with a reduced risk of T2DM. These mutations lead to a loss of function in ZnT8, altering its structure and function, which is thought to enhance insulin secretion and improve glucose response (Sui2023ZnT8; BarragánÁlvarez2021Loss). Conversely, the common R325W polymorphism is linked to an increased risk of T2DM, as it results in a less active zinc transporter, affecting insulin storage and secretion (Davidson2014Zinc; Mitchell2016Molecular).

The SLC30A8 gene also plays a role in insulin clearance. In ZnT8 knockout mice, increased hepatic insulin clearance was observed, leading to lower peripheral insulin levels despite increased secretion from pancreatic β cells. This suggests that SLC30A8 mutations can affect insulin availability and glucose homeostasis, potentially contributing to diabetes susceptibility (Tamaki2013The). The gene's expression is influenced by factors such as zinc levels and glucose, which are crucial for maintaining proper β cell function and insulin homeostasis (Davidson2014Zinc).

## Interactions
The SLC30A8 gene encodes the zinc transporter 8 (ZnT8) protein, which is primarily expressed in pancreatic islet cells. ZnT8 is involved in zinc uptake into secretory granules, a process crucial for insulin storage and secretion. The protein interacts with several other proteins, forming a network that influences its function in glucose metabolism and insulin regulation. Notably, SLC30A8 interacts with proteins such as GAD2, SLC30A6, G6PC2, INS, PTPRN, HHEX, KCNJ11, TCF7L2, IGF2BP2, and CDKAL1. These interactions are significant in the context of type 1 diabetes mellitus (T1DM), as they are involved in pathways like the TRAIL signaling pathway and the Insulin Pathway (Bhatty2021Identification).

The interaction with INS (insulin) is particularly emphasized due to its known involvement in T1DM pathogenesis. Additionally, TCF7L2 is identified as an upstream regulator of SLC30A8, potentially modifying β-cell zinc release and insulin clearance (Mitchell2016Molecular). These interactions suggest that SLC30A8 plays a critical role in maintaining glucose homeostasis and may influence insulin and glucagon release, highlighting its importance in diabetes research (Mitchell2016Molecular).


## References


[1. (Weijers2010Threedimensional) Rob NM Weijers. Three-dimensional structure of β-cell-specific zinc transporter, znt-8, predicted from the type 2 diabetes-associated gene variant slc30a8 r325w. Diabetology &amp; Metabolic Syndrome, June 2010. URL: http://dx.doi.org/10.1186/1758-5996-2-33, doi:10.1186/1758-5996-2-33. This article has 28 citations.](https://doi.org/10.1186/1758-5996-2-33)

[2. (Chimienti2006In) Fabrice Chimienti, Séverine Devergnas, François Pattou, Frans Schuit, Rachel Garcia-Cuenca, Brigitte Vandewalle, Julie Kerr-Conte, Leentje Van Lommel, Didier Grunwald, Alain Favier, and Michel Seve. In vivo expression and functional characterization of the zinc transporter znt8 in glucose-induced insulin secretion. Journal of Cell Science, 119(20):4199–4206, October 2006. URL: http://dx.doi.org/10.1242/jcs.03164, doi:10.1242/jcs.03164. This article has 281 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.03164)

[3. (Flannick2016SLC30A8:) Jason Flannick and William L. Lowe. SLC30A8: A Complex Road from Association to Function, pages 379–401. Springer International Publishing, 2016. URL: http://dx.doi.org/10.1007/978-3-319-01574-3_18, doi:10.1007/978-3-319-01574-3_18. This article has 1 citations.](https://doi.org/10.1007/978-3-319-01574-3_18)

[4. (Sui2023ZnT8) Lina Sui, Qian Du, Anthony Romer, Qi Su, Pauline L. Chabosseau, Yurong Xin, Jinrang Kim, Sandra Kleiner, Guy A. Rutter, and Dieter Egli. Znt8 loss of function mutation increases resistance of human embryonic stem cell-derived beta cells to apoptosis in low zinc condition. Cells, 12(6):903, March 2023. URL: http://dx.doi.org/10.3390/cells12060903, doi:10.3390/cells12060903. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12060903)

[5. (BarragánÁlvarez2021Loss) Carla P. Barragán-Álvarez, Eduardo Padilla-Camberos, Nestor F. Díaz, Agustín Cota-Coronado, Claudia Hernández-Jiménez, Carlos C. Bravo-Reyna, and Nestor E. Díaz-Martínez. Loss of znt8 function in diabetes mellitus: risk or benefit? Molecular and Cellular Biochemistry, 476(7):2703–2718, March 2021. URL: http://dx.doi.org/10.1007/s11010-021-04114-4, doi:10.1007/s11010-021-04114-4. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-021-04114-4)

[6. (Lu2007Structure) Min Lu and Dax Fu. Structure of the zinc transporter yiip. Science, 317(5845):1746–1748, September 2007. URL: http://dx.doi.org/10.1126/science.1143748, doi:10.1126/science.1143748. This article has 335 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1143748)

[7. (Mitchell2016Molecular) Ryan K. Mitchell, Ming Hu, Pauline L. Chabosseau, Matthew C. Cane, Gargi Meur, Elisa A. Bellomo, Raffaella Carzaniga, Lucy M. Collinson, Wen-Hong Li, David J. Hodson, and Guy A. Rutter. Molecular genetic regulation of slc30a8/znt8 reveals a positive association with glucose tolerance. Molecular Endocrinology, 30(1):77–91, January 2016. URL: http://dx.doi.org/10.1210/me.2015-1227, doi:10.1210/me.2015-1227. This article has 60 citations.](https://doi.org/10.1210/me.2015-1227)

[8. (Bhatty2021Identification) Afreen Bhatty, Zile Rubab, Hafiz Syed Mohammad Osama Jafri, and Sheh Zano. Identification of dysregulated pathways through &lt;i&gt;slc30a8&lt;/i&gt; protein interaction in type 1 diabetes mellitus. AIMS Molecular Science, 8(4):301–310, 2021. URL: http://dx.doi.org/10.3934/molsci.2021023, doi:10.3934/molsci.2021023. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3934/molsci.2021023)

[9. (Wong2017Exploring) Winifred P. Wong, Norrina B. Allen, Matthew S. Meyers, Emma O. Link, Xiaomin Zhang, Keith W. MacRenaris, and Malek El Muayed. Exploring the association between demographics, slc30a8 genotype, and human islet content of zinc, cadmium, copper, iron, manganese and nickel. Scientific Reports, March 2017. URL: http://dx.doi.org/10.1038/s41598-017-00394-3, doi:10.1038/s41598-017-00394-3. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-00394-3)

[10. (Tamaki2013The) Motoyuki Tamaki, Yoshio Fujitani, Akemi Hara, Toyoyoshi Uchida, Yoshifumi Tamura, Kageumi Takeno, Minako Kawaguchi, Takahiro Watanabe, Takeshi Ogihara, Ayako Fukunaka, Tomoaki Shimizu, Tomoya Mita, Akio Kanazawa, Mica O. Imaizumi, Takaya Abe, Hiroshi Kiyonari, Shintaro Hojyo, Toshiyuki Fukada, Takeshi Kawauchi, Shinya Nagamatsu, Toshio Hirano, Ryuzo Kawamori, and Hirotaka Watada. The diabetes-susceptible gene slc30a8/znt8 regulates hepatic insulin clearance. Journal of Clinical Investigation, 123(10):4513–4524, September 2013. URL: http://dx.doi.org/10.1172/jci68807, doi:10.1172/jci68807. This article has 198 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci68807)

[11. (Kambe2012Molecular) Taiho Kambe. Molecular Architecture and Function of ZnT Transporters, pages 199–220. Elsevier, 2012. URL: http://dx.doi.org/10.1016/b978-0-12-394390-3.00008-2, doi:10.1016/b978-0-12-394390-3.00008-2. This article has 75 citations.](https://doi.org/10.1016/b978-0-12-394390-3.00008-2)

[12. (Davidson2014Zinc) Howard W. Davidson, Janet M. Wenzlau, and Richard M. O’Brien. Zinc transporter 8 (znt8) and β cell function. Trends in Endocrinology &amp; Metabolism, 25(8):415–424, August 2014. URL: http://dx.doi.org/10.1016/j.tem.2014.03.008, doi:10.1016/j.tem.2014.03.008. This article has 125 citations.](https://doi.org/10.1016/j.tem.2014.03.008)